Seneca Biopharma completes cell manufacturing facility in Suzhou, China
Seneca Biopharma (formerly Neuralstem), a biopharma company engaged in developing treatments for diseases of high unmet medical need, has completed construction on its new cell manufacturing facility in Suzhou, China. The cell manufacturing facility will be used for manufacture NSI-566, the lead stem cell therapy of Seneca Biopharma for clinical trials in China, which includes […]